A total of 199 plasma proteins were found to be significantly associated with bladder cancer risk, among which five proteins (SLURP1, LY6D, WFDC1, NOV, and GSTM3) emerged as core candidate targets. Here, WFDC1 is linked to urinary bladder cancer.